Skip to main content
. 2023 Jan 18;15(3):502. doi: 10.3390/nu15030502

Figure 1.

Figure 1

Effects of PVN luteolin on blood pressure, the plasma levels of NE, and EPI. (A) Structural formula of luteolin. (B) Schematic representation of microinjection sites. (C) The systolic blood pressure (SBP) in different groups. (D) The diastolic blood pressure (DBP) in different groups. (E) The mean arterial pressure (MAP) in different groups. (F) Heart rate (HR) in different groups. (G) ELISA detection of the plasma level of EPI in different groups. (H) ELISA detection of plasma level NE in different groups. Values are mean ± SEM. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus WKY groups (WKY + PVN vehicle or WKY + PVN luteolin); † p < 0.05 SHR + PVN vehicle versus SHR + PVN luteolin.